Resource Logo
Health-E

Phase out D4T in poor countries




 

In 2010 the World Health Organisation (WHO) changed the HIV treatment guidelines for poor countries and recommended switching from stavudine (D4T) to tenofovir disoproxil fumarate (TDF) for all patients on first line treatment. OPINION by Vuyiseka Dubula (Quackdown)

Stavudine (D4T) was previously one of three antiretroviral drugs (ARVs) recommended as first-line treatment but serious side effects, seen in many studies and treatment programmes, led to calls to use better, less toxic drugs. Click here to read more on Quackdown.



 


Health-e is a news agency that produces news and in-depth analysis for the print and electronic media. Their particular focus is HIV/AIDS, public health and issues regarding health policy and practice in South Africa. They provide print features for newspapers and magazines and well as broadcast packages for national and community radio stations. They also accept commissions. 



Information in this article was accurate in November 7, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.